You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Eli Lilly and Company announces Q2 2023 dividend
2 May 2023 -

Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Monday its dividend for the second quarter of 2023.

The company has declared a dividend of USD1.13 per share on outstanding common stock.

The dividend will be paid to shareholders of record at 15 May 2023 on 9 June 2023.

Login
Username:

Password:


Related Headlines

Puma Biotechnology Posts 1Q23 Results

Pfizer declares results for first-quarter 2023

Eli Lilly and Company announces Q2 2023 dividend

Report Looks at Global Neurology Clinical Trials Market

Boehringer Ingelheim reports strong 2022 performance

Navamedic ASA announces cash offer to acquire all Sensidose AB shares

Navamedic announces cash offer to acquire Sensidose for approximately SEK75m

European Commission Grants Orphan Designation for iECURE's Lead Product Candidate GTP-506 for the Treatment of Ornithine Transcarbamylase Deficiency

Xeris Biopharma achieves fourth quarter net product revenue of USD32.5m

Amgen announces Q2 2023 dividend

West Pharmaceutical Services declares Q2 2022 dividend

Nordic Nanovector ASA reports full year results for 2022

Devyser Diagnostics AB announces full year 2022 results

Abbott announces quarterly common dividend

AbbVie Inc announces quarterly cash dividend

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2023